3-D Matrix Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
129
- Stock Symbol
-
7777
- Investments
-
2
- Share Price
-
$1.89
- (As of Tuesday Closing)
3-D Matrix General Information
Description
3-D Matrix Ltd is engaged in the research, development, manufacture, and sale of medical devices based on the self-assembling peptide technology. Additionally, the company develops ready-to-use hemostatic gels, mucosal elevation agents, and sealants to manage bleeding during complex procedures in gastroenterology, cardiac surgery, ENT, and urology. Its product portfolio includes PuraMatrix, High Concentration PuraMatrix, Modified Peptide and GMP Grade PuraMatrix.
Contact Information
Website
www.3d-matrix.co.jpCorporate Office
- 3-2-4 Kojimachi, Chiyoda-ku
- 7th floor, Kojimachi HF Building
- Tokyo, 102-0083
- Japan
Corporate Office
- 3-2-4 Kojimachi, Chiyoda-ku
- 7th floor, Kojimachi HF Building
- Tokyo, 102-0083
- Japan
3-D Matrix Stock Performance
As of 17-Nov-2026, 3-D Matrix’s stock price is $1.89. Its current market cap is $241M with 128M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.89 | $1.93 | $1.79 - $5.01 | $241M | 128M | 2.14M | $0.20 |
3-D Matrix Financials Summary
As of 31-Jul-2026, 3-D Matrix has a trailing 12-month revenue of $76.5M.
|
In Thousands, USD |
TTM 31-Jul-2026 | FY 2026 30-Apr-2026 | FY 2025 30-Apr-2025 | FY 2024 30-Apr-2024 |
|---|---|---|---|---|
| EV | 248,907 | 377,707 | 104,712 | 79,457 |
| Revenue | 76,517 | 71,645 | 45,704 | 31,395 |
| EBITDA | 27,428 | |||
| Net Income | 23,714 | 27,350 | (16,486) | (1,748) |
| Total Assets | 58,687 | 61,150 | 45,759 | 37,653 |
| Total Debt | 3,745 | 3,746 | 20,660 | 26,699 |
3-D Matrix Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
3-D Matrix Patents
3-D Matrix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026064790-A1 | Novel peptide compositions and their use for the treatment of skin and mucous membrane wounds and in cosmetic applications | Pending | 23-Sep-2024 | ||
| US-20260083817-A1 | Peptide compositions and their use for the treatment of skin and mucous membrane wounds and in cosmetic applications | Pending | 23-Sep-2024 | ||
| AU-2025229739-A1 | Controlled-release formulations of glp-1 receptor agonists utilizing self-assembling peptides (saps) | Pending | 28-Feb-2024 | ||
| WO-2025184112-A1 | Controlled-release formulations of glp-1 receptor agonists utilizing self-assembling peptides (saps) | Pending | 28-Feb-2024 | ||
| JP-2025113084-A | Intestinal disease mucosal healing agent for subcutaneous administration | Pending | 22-Jan-2024 |
3-D Matrix Signals
3-D Matrix Investments & Acquisitions (2)
3-D Matrix’s most recent deal was a Merger/Acquisition with 3-D Matrix (Boston, Massachusetts).
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 3-D Matrix (Boston, Massachusetts) | Merger/Acquisition | Drug Discovery | |||
| PURMX Therapeutics | Seed Round | Drug Discovery |
3-D Matrix ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
3-D Matrix Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| 3-D Matrix EMEA | Hoofddorp, Netherlands | 2015 |
3-D Matrix FAQs
-
When was 3-D Matrix founded?
3-D Matrix was founded in 2004.
-
Where is 3-D Matrix headquartered?
3-D Matrix is headquartered in Tokyo, Japan.
-
What is the size of 3-D Matrix?
3-D Matrix has 129 total employees.
-
What industry is 3-D Matrix in?
3-D Matrix’s primary industry is Biotechnology.
-
Is 3-D Matrix a private or public company?
3-D Matrix is a Public company.
-
What is 3-D Matrix’s stock symbol?
The ticker symbol for 3-D Matrix is 7777.
-
What is the current stock price of 3-D Matrix?
As of 17-Nov-2026 the stock price of 3-D Matrix is $1.89.
-
What is the current market cap of 3-D Matrix?
The current market capitalization of 3-D Matrix is $241M.
-
What is 3-D Matrix’s current revenue?
The trailing twelve month revenue for 3-D Matrix is $76.5M.
-
What is 3-D Matrix’s annual earnings per share (EPS)?
3-D Matrix’s EPS for 12 months was $0.20.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process